- Home
- ENSC vs DSS Comparison
ENSC vs DSS Comparison
Compare ENSC & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- DSS
- Stock Information
- Founded
- ENSC 2003
- DSS 1984
- Country
- ENSC United States
- DSS United States
- Employees
- ENSC N/A
- DSS N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- ENSC Health Care
- DSS Consumer Discretionary
- Exchange
- ENSC Nasdaq
- DSS Nasdaq
- Market Cap
- ENSC 7.9M
- DSS 7.3M
- IPO Year
- ENSC N/A
- DSS N/A
- Fundamental
- Price
- ENSC $5.40
- DSS $0.94
- Analyst Decision
- ENSC
- DSS
- Analyst Count
- ENSC 0
- DSS 0
- Target Price
- ENSC N/A
- DSS N/A
- AVG Volume (30 Days)
- ENSC 26.4K
- DSS 17.2K
- Earning Date
- ENSC 03-14-2025
- DSS 03-26-2025
- Dividend Yield
- ENSC N/A
- DSS N/A
- EPS Growth
- ENSC N/A
- DSS N/A
- EPS
- ENSC N/A
- DSS N/A
- Revenue
- ENSC $4,421,404.00
- DSS $25,019,000.00
- Revenue This Year
- ENSC $89.78
- DSS N/A
- Revenue Next Year
- ENSC N/A
- DSS N/A
- P/E Ratio
- ENSC N/A
- DSS N/A
- Revenue Growth
- ENSC 40.41
- DSS N/A
- 52 Week Low
- ENSC $2.12
- DSS $0.77
- 52 Week High
- ENSC $14.67
- DSS $2.30
- Technical
- Relative Strength Index (RSI)
- ENSC 35.78
- DSS 55.12
- Support Level
- ENSC $5.34
- DSS $0.90
- Resistance Level
- ENSC $6.14
- DSS $0.96
- Average True Range (ATR)
- ENSC 0.43
- DSS 0.06
- MACD
- ENSC -0.04
- DSS 0.01
- Stochastic Oscillator
- ENSC 9.49
- DSS 76.96
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.